MaxCyte Interest Coverage
The Interest Coverage Ratio of MaxCyte (MXCT) as of Sep 5, 2026 is -5.05. In the previous year, Interest Coverage Ratio was -4.65 — a change of 8.45% (lower).
Get this data via API
Financial Data API
Interest Coverage
-5.05
YoY
8.45%
Last updated:
The MaxCyte Interest Coverage history
3 Years
10 Years
25 Years
Max
| YEAR | Interest Coverage | YoY |
|---|---|---|
| -5.05 | +8.45% | |
| -4.65 | -35.52% | |
| -7.22 | -64.68% | |
| -20.44 | +40.44% | |
| -14.55 | -43.76% | |
| -25.88 | +35.21% | |
| -19.14 | +29.77% | |
| -14.75 | +246.97% | |
| -4.25 | +291.45% | |
| -1.09 | -52.50% | |
| -2.29 | — |
MaxCyte Stock analysis
Frequently Asked Questions about MaxCyte stock
Interest Coverage Ratio of MaxCyte is -5.05 in 2026.
Interest Coverage Ratio of MaxCyte changed from -4.65 to -5.05, representing a 8.45% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Interest Coverage Ratio MaxCyte since 2006 – with annual values, charts, and detailed analysis.
The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.
Interest Coverage = EBIT / Interest Expense
A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's MaxCyte with sector peers and the industry average to assess whether it is attractive.
Leverage — MaxCyte
All Key Metrics — MaxCyte
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth